Immuneering Corporation
NASDAQ:IMRX
1.45 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 36,144.72 | 59.406 | 72.637 | 74.888 | 37.09 | 13.782 |
| Short Term Investments
| 0 | 26.26 | 32.888 | 74.311 | 0 | 0 |
| Cash and Short Term Investments
| 36,144.72 | 85.666 | 105.525 | 149.199 | 37.09 | 13.782 |
| Net Receivables
| 0 | 0 | 0.012 | 0.246 | 0.5 | 0.21 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 3,442.849 | 3.418 | 3.21 | 2.889 | 0.141 | 0.071 |
| Total Current Assets
| 39,587.569 | 89.084 | 108.747 | 152.334 | 37.731 | 14.063 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 4,790.217 | 5.396 | 5.777 | 6.131 | 0.677 | 0.035 |
| Goodwill
| 6.69 | 6.69 | 6.69 | 6.702 | 0 | 0 |
| Intangible Assets
| 0.35 | 0.38 | 0.409 | 0.439 | 0 | 0 |
| Goodwill and Intangible Assets
| 7,040.844 | 7.07 | 7.099 | 7.141 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0.997 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0.046 | 0.022 |
| Other Non-Current Assets
| 1,295.783 | 1.034 | 0.744 | 0.102 | -0.032 | -0.022 |
| Total Non-Current Assets
| 13,126.844 | 13.501 | 13.62 | 14.371 | 0.692 | 0.035 |
| Total Assets
| 52,714.413 | 102.585 | 122.367 | 166.705 | 38.423 | 14.099 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.959 | 2.112 | 3.155 | 1.394 | 1.481 | 0.295 |
| Short Term Debt
| 0.338 | 0.3 | 0.379 | 0.274 | 0.076 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 7,501.471 | 5.434 | 4.521 | 3.965 | 0.699 | 0.21 |
| Total Current Liabilities
| 7,503.768 | 7.846 | 8.054 | 5.634 | 2.256 | 0.505 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 3,828.243 | 4.163 | 4.463 | 5.091 | 0.545 | 16.612 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | -0.046 | -16.634 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0.046 | 0.022 |
| Other Non-Current Liabilities
| -3.824 | 0 | 0 | 0 | 58.104 | 3.508 |
| Total Non-Current Liabilities
| 3,824.419 | 4.163 | 4.463 | 5.091 | 58.649 | 20.12 |
| Total Liabilities
| 11,328.187 | 12.008 | 12.517 | 10.725 | 60.904 | 20.626 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 122,367.283 | 166,704.832 | 58.104 | 16.612 |
| Common Stock
| 0.031 | 0.029 | 0.026 | 0.026 | 0.005 | 0.005 |
| Retained Earnings
| -224,295.186 | -163.259 | -109.787 | -59.273 | -25.738 | -8.698 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.001 | -0.03 | -0.049 | -58.104 | -16.612 |
| Other Total Stockholders Equity
| 265,681.381 | 253.806 | -122,147.642 | -166,489.556 | 61.355 | 18.778 |
| Total Shareholders Equity
| 41,386.226 | 90.576 | 109.85 | 155.98 | -22.481 | -6.527 |
| Total Equity
| 41,386.226 | 90.576 | 109.85 | 155.98 | -22.481 | -6.527 |
| Total Liabilities & Shareholders Equity
| 52,714.413 | 102.585 | 122.367 | 166.705 | 38.423 | 14.099 |